• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human E3 ubiquitin-protein ligase ARIH1 (ARIH1)

ACP09624

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP09624 Target NameARIH1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-557Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9Y4X5
Background Information
  • Uniprot Id

    Q9Y4X5

  • Target Species

    Human

  • Target Name

    ARIH1

  • Target Full Name

    E3 ubiquitin-protein ligase ARIH1

  • Target Function

    E3 ubiquitin-protein ligase, which catalyzes ubiquitination of target proteins together with ubiquitin-conjugating enzyme E2 UBE2L3. Acts as an atypical E3 ubiquitin-protein ligase by working together with cullin-RING ubiquitin ligase (CRL) complexes and initiating ubiquitination of CRL substrates: associates with CRL complexes and specifically mediates addition of the first ubiquitin on CRLs targets. The initial ubiquitin is then elongated by CDC34/UBE2R1 and UBE2R2. E3 ubiquitin-protein ligase activity is activated upon binding to neddylated cullin-RING ubiquitin ligase complexes. Plays a role in protein translation in response to DNA damage by mediating ubiquitination of EIF4E2, the consequences of EIF4E2 ubiquitination are however unclear. According to a report, EIF4E2 ubiquitination leads to promote EIF4E2 cap-binding and protein translation arrest. According to another report EIF4E2 ubiquitination leads to its subsequent degradation. Acts as the ligase involved in ISGylation of EIF4E2. In vitro, controls the degradation of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex member SUN2 and may therefore have a role in the formation and localization of the LINC complex, and as a consequence, nuclear subcellular localization and nuclear morphology

  • Target Subcellular Location

    Cytoplasm. Nucleus. Nucleus, Cajal body.

  • Target Protein Families

    RBR family, Ariadne subfamily

  • Target Tissue Specificity

    Widely expressed.

  • Target Synonyms

    ARI 1; ARI; ARI-1; ARI1; ARI1_HUMAN; Ariadne Drosophila homolog of; Ariadne homolog; Ariadne homolog ubiquitin conjugating enzyme E2 binding protein 1; Ariadne ubiquitin conjugating enzyme E2 binding protein homolog 1; ARIH 1; ARIH1; E3 ubiquitin protein ligase ARIH1; H7 AP2; H7-AP2; HARI; HHARI; human homologue of ariadne ; Monocyte protein 6; MOP 6; MOP-6; MOP6; Protein ariadne 1 homolog; Protein ariadne-1 homolog; Protein ariadne1 homolog; UbcH7 binding protein; UBCH7 BP; UbcH7-binding protein; UBCH7BP; UbcM4 interacting protein; UbcM4-interacting protein; Ubiquitin conjugating enzyme E2 binding protein 1; Ubiquitin-conjugating enzyme E2-binding protein 1

  • Target Background

    Enables enzyme binding activity; ubiquitin-protein transferase activity; and zinc ion binding activity. Involved in protein ubiquitination. Located in Lewy body; cytoplasm; and nuclear body. Colocalizes with cullin-RING ubiquitin ligase complex.

Inquire Recombinant Human E3 ubiquitin-protein ligase ARIH1 (ARIH1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification